Clinical Trials
30 trialsA Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Memorial Sloan Kettering Cancer Center
BMT
Massachusetts General Hospital
The Sequestration of Holistic Stress Management Techniques for Adults
Virtual Tribunal Monastery
BMT CTN 1702
Center for International Blood and Marrow Transplant Research
Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
Washington University School of Medicine
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
New York Medical College
PiCASO
Duke University
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Roswell Park Cancer Institute
ORCHARD
University of Aberdeen
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Columbia University
Patient-Empowered Mobile Technology in Hospitalized Patients (TRU-PAIN)
Duke University
SELF-BREATHE RCT for Chronic Breathlessness
King's College Hospital NHS Trust
COVID-19 Testing in Underserved and Vulnerable Populations
University of California, San Diego
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
Bellicum Pharmaceuticals
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Bellicum Pharmaceuticals
GBT_HOPE
Pfizer
HCTDiet
University of Virginia
OMNI-Can
OMNI Medical Services, LLC
Distracting Through Procedural Pain and Distress
Medical College of Wisconsin
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
Duke University
Kid Cards: Teaching Kids About Medicines
Children's Mercy Hospital Kansas City
FOCUS
Georgia State University
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia
Emmaus Medical, Inc.
SUSTAIN
Reprixys Pharmaceutical Corporation
Massive Iron Deposit Assessment
St. Jude Children's Research Hospital
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
MAPLE
Brigham and Women's Hospital
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
Teva Branded Pharmaceutical Products R&D, Inc.
Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
Endo Pharmaceuticals